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The title compound, C18H20N4O2S2, is a new 1,3,4-oxadiazole and a key
pharmacophore of several biologically active agents. It is composed of a
methyl(thiophen-2-yl)-1,3,4-oxadiazole-2(3H)-thione moiety linked to a
2-methoxyphenyl unit via a piperazine ring that has a chair conformation. The
thiophene ring mean plane lies almost in the plane of the oxadiazole ring, with a
dihedral angle of 4.35 (9). The 2-methoxyphenyl ring is almost normal to the
oxadiazole ring, with a dihedral angle of 84.17 (10). In the crystal, molecules are
linked by weak C—H  S hydrogen bonds and C—H   interactions, forming
layers parallel to the bc plane. The layers are linked via weak C—H  O
hydrogen bonds and slipped parallel – interactions [intercentroid distance =
3.6729 (10) A˚], forming a three-dimensional structure. The thiophene ring has
an approximate 180 rotational disorder about the bridging C—C bond.
1. Chemical context
1,3,4-Oxadiazole derivatives are structural motifs of particular
value in material sciences (Zhang et al., 2011) and agro-
chemistry (Shi et al., 2001; Milinkevich et al., 2009; Li et al.,
2014). In addition, they occupy a unique situation in the field
of medicinal chemistry as pharmacophores possessing diverse
pharmacological activities including antibacterial (Ogata et al.,
1971; Rane et al., 2012; Al-Omar, 2010), anticancer (Pinna et
al., 2009; Gamal El-Din et al., 2015; Zhang et al., 2014; Du et al.,
2013), antiviral (Summa et al., 2008; Wu et al., 2015; El-Emam
et al., 2004), antihypertensive (Vardan et al., 1983; Schlecker &
Thieme, 1988), anti-inflammatory (Bansal et al., 2014; Kadi et
al., 2007) and anti-oxidant (Ma et al., 2013) activities. In
continuation to our previous studies on 1,3,4-oxadiazoles (El-
Emam et al., 2012), we report herein on the synthesis and
crystal structure of the title compound.
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2. Structural commentary
The title compound, Fig. 1, is composed of a methyl(thiophen-
2-yl)-1,3,4-oxadiazole-2(3H)-thione moiety linked to a
2-methoxyphenyl unit via a bridging piperazine ring. The
molecule is V-shaped with the mean plane of the piperazine
ring, that has a chair conformation, making dihedral angles of
51.2 (1) and 77.8 (1) with the 2-methoxyphenyl ring and the
oxadiazole ring, respectively. The thiophene ring mean plane
lies almost in the plane of the oxadiazole ring, with a dihedral
angle of 4.35 (9). The thiophene ring has an approximate 180
rotational disorder about the bridging C14—C15 bond.
3. Supramolecular features
In the crystal, molecules are linked by weak C—H  S
hydrogen bonds and C—H   interactions, forming layers in
the bc plane (Table 1 and Fig. 2). The layers are linked via
C—H  O hydrogen bonds and slipped parallel – inter-
actions [Cg3   Cg1i = 3.6729 (10) A˚, inter-planar distance =
3.4757 (7) A˚, slippage = 0.967 A˚; Cg1 and Cg3 are the
centroids of the S2A/C15/C16A/C17/C18 and O1/ N3/N4/C13/
C14 rings, respectively; symmetry code (i): x + 2, y + 1,
z + 2], forming a three-dimensional structure (Table 1 and
Fig. 2).
4. Database survey
A search of the Cambridge Structural Database (Version 5.37,
last update November 2015; Groom & Allen, 2014) for the
3-methyl-5-(thiophen-2-yl)-1,3,4-oxadiazole-2(3H)-thione
moiety of the title compound gave three hits. Two of these
compounds also contain a substituted piperazine ring, namely
3-[(4-phenylpiperazin-1-yl)methyl]-5-(2-thienyl)-1,3,4-oxa-
diazole-2(3H)-thione (IDOBUA; El-Emam et al., 2013) and
3-[(4-benzylpiperazin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-di-
hydro-1,3,4-oxadiazole-2-thione (VUBYUO; Al-Omary et al.,
2015). In both of these molecules, the conformation is very
similar to that of the title compound.
5. Synthesis and crystallization
To a solution of 5-(thiophen-2-yl)-1,3,4-oxadiazole-2-thiol
(920 mg, 5 mmol), in ethanol (15 ml), 1-(2-methoxyphenyl)-
piperazine (960 mg, 5 mmol) and 37% formaldehyde solution
(1.0 ml) were added and the mixture was stirred at room
temperature for 3 h and then allowed to stand overnight at
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Figure 1
The molecular structure of the title compound, showing the atom-
labelling scheme and displacement ellipsoids at the 50% probability level.
The thiophene ring has an approximate 180 rotational disorder about the
bridging C—C bond.
Table 1
Hydrogen-bond geometry (A˚, ).
Cg1 is the centroid of the S2A/C15/C16A/C17/C18 ring.
D—H  A D—H H  A D  A D—H  A
C12—H12A  S1i 0.97 2.95 3.860 (2) 157
C17—H17  O1ii 0.93 2.69 3.475 (2) 143
C5—H5  Cg1iii 0.93 2.95 3.660 (2) 135
Symmetry codes: (i) x;y þ 12; z 12; (ii) xþ 2; yþ 12;zþ 52; (iii)x þ 1;yþ 1;zþ 2.
Figure 2
Crystal packing of the title compound, viewed along the b axis, showing
the C—H  S and C—H  O hydrogen bonds (Table 1) as dashed lines.
Only H atoms involved in intermolecular interactions have been
included.
room temperature. The precipitated crude product was
filtered, washed with cold ethanol, dried, and crystallized from
ethanol to yield the title compound as pale-yellow prismatic
crystals(yield 1.67 g, 86%; m.p. 419–421 K). Single crystals
suitable for X-ray analysis were obtained by slow evaporation
of a CHCl3:EtOH solution (1:1; 15 ml) at room temperature.
1H NMR (CDCl3, 500.13 MHz):  3.10 (s, 8H, piperazine-H),
3.85 (s, 3H, OCH3), 5.15 (s, 2H, CH2), 6.85–6.87 (m, 1H, Ar-
H), 6.92–6.95 (m, 2H, Ar-H), 7.01–7.03 (m, 1H, Ar-H), 7.18 (t,
1H, thiophene-H, J = 4.5 Hz), 7.59 (d, 1H, thiophene-H, J =
4.5 Hz), 7.75 (d, 1H, thiophene-H, J = 4.5 Hz). 13C NMR
(CDCl3, 125.76 MHz):  50.43, 50.64 (piperazine-C), 55.33
(OCH3), 70.44 (CH2), 111.05, 118.28, 120.94, 123.17, 123.68,
128.32, 130.74, 130.95, 141.09, 152.23 (Ar & thiophene-C),
155.42 (C N), 177.74 (C S).
6. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 2. The C-bound H atoms were
positioned geometrically and treated as riding atoms: C—H
0.95–0.97 A˚ with Uiso(H) = 1.5Ueq(C-methyl) and 1.2Ueq(C)
for other H atoms. The thienyl ring is disordered over two
positions and in the final refinement cycles, the occupancy of
atoms S2A and C16A, and S2B and C16B, were each fixed at
0.5.
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Data collection
Diffractometer Agilent Xcalibur Ruby Gemini
Absorption correction Multi-scan (CrysAlis PRO;
Agilent, 2014)
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Computing details 
Data collection: CrysAlis CCD (Oxford Diffraction, 2006); cell refinement: CrysAlis CCD (Oxford Diffraction, 2006); 
data reduction: CrysAlis RED (Oxford Diffraction, 2006); program(s) used to solve structure: SHELXS97 (Sheldrick, 
2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows 
(Farrugia, 2012) and Mercury (Macrae et al., 2008); software used to prepare material for publication: WinGX (Farrugia, 






Hall symbol: -P 2ybc
a = 15.2925 (2) Å
b = 10.0745 (1) Å
c = 11.9726 (1) Å
β = 93.413 (1)°
V = 1841.28 (3) Å3
Z = 4
F(000) = 816
Dx = 1.401 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 11296 reflections
θ = 3.7–70.5°
µ = 2.80 mm−1
T = 100 K
Prism, colourless
0.70 × 0.51 × 0.41 mm
Data collection 
Agilent Xcalibur Ruby Gemini 
diffractometer
Radiation source: Enhance (Cu) X-ray Source
Graphite monochromator
Detector resolution: 10.2673 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis PRO; Agilent, 2014)
Tmin = 0.225, Tmax = 0.315
13494 measured reflections
3545 independent reflections
3401 reflections with I > 2σ(I)
Rint = 0.026
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Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0574P)2 + 2.048P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.95 e Å−3
Δρmin = −0.65 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq Occ. (<1)
S1 0.89998 (3) 0.09896 (5) 0.99378 (4) 0.02414 (15)
S2A 0.87403 (4) 0.74266 (6) 1.04820 (5) 0.02497 (16) 0.7913 (14)
C16A 0.94021 (8) 0.57554 (13) 1.21094 (10) 0.02497 (16) 0.7913 (14)
H16A 0.9598 0.501 1.2508 0.03* 0.7913 (14)
S2B 0.94021 (8) 0.57554 (13) 1.21094 (10) 0.02497 (16) 0.2087 (14)
C16B 0.87403 (4) 0.74266 (6) 1.04820 (5) 0.02497 (16) 0.2087 (14)
H16B 0.8502 0.779 0.9817 0.03* 0.2087 (14)
O1 0.90631 (8) 0.35048 (13) 1.06190 (11) 0.0189 (3)
O2 0.43793 (9) 0.38449 (17) 0.90935 (12) 0.0312 (4)
N3 0.85646 (10) 0.33316 (16) 0.89001 (13) 0.0192 (3)
N1 0.55319 (10) 0.37224 (16) 0.74811 (13) 0.0198 (3)
N4 0.85770 (10) 0.46847 (16) 0.91387 (13) 0.0204 (3)
N2 0.73225 (10) 0.29806 (17) 0.75238 (13) 0.0210 (3)
C1 0.46191 (12) 0.37565 (18) 0.71654 (16) 0.0202 (4)
C15 0.90176 (11) 0.58606 (19) 1.08927 (15) 0.0183 (4)
C14 0.88737 (11) 0.47285 (19) 1.01696 (15) 0.0180 (4)
C13 0.88567 (12) 0.26006 (19) 0.97769 (15) 0.0187 (4)
C6 0.40227 (13) 0.3813 (2) 0.80197 (17) 0.0229 (4)
C9 0.67626 (13) 0.2461 (2) 0.83683 (17) 0.0237 (4)
H9A 0.6806 0.3025 0.9026 0.028*
H9B 0.6955 0.1577 0.8589 0.028*
C11 0.61058 (12) 0.4202 (2) 0.66366 (16) 0.0231 (4)
H11A 0.5908 0.5066 0.6368 0.028*
H11B 0.6088 0.3596 0.6007 0.028*
C4 0.28120 (13) 0.3853 (2) 0.66375 (19) 0.0278 (5)
H4 0.2211 0.3875 0.6463 0.033*
C3 0.33874 (14) 0.3826 (2) 0.57913 (18) 0.0284 (5)
H3 0.3177 0.3844 0.5046 0.034*
C2 0.42871 (13) 0.3770 (2) 0.60627 (17) 0.0249 (4)
H2 0.4672 0.3741 0.5491 0.03*
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C10 0.70379 (12) 0.4304 (2) 0.71497 (16) 0.0228 (4)
H10A 0.7424 0.4638 0.66 0.027*
H10B 0.7058 0.4912 0.7779 0.027*
C8 0.58162 (13) 0.2411 (2) 0.78978 (18) 0.0240 (4)
H8A 0.5763 0.177 0.7292 0.029*
H8B 0.5441 0.2125 0.8478 0.029*
C5 0.31283 (13) 0.3849 (2) 0.77469 (18) 0.0275 (5)
H5 0.2738 0.3869 0.8313 0.033*
C12 0.82390 (12) 0.2821 (2) 0.77866 (15) 0.0224 (4)
H12A 0.8555 0.3268 0.7217 0.027*
H12B 0.8379 0.1883 0.7749 0.027*
C17 0.93757 (13) 0.7167 (2) 1.24746 (17) 0.0268 (4)
H17 0.9571 0.7421 1.3193 0.032*
C7 0.38537 (15) 0.4430 (3) 0.99152 (19) 0.0342 (5)
H7A 0.4167 0.4403 1.0634 0.051*
H7B 0.3316 0.3943 0.9947 0.051*
H7C 0.3726 0.5335 0.9715 0.051*
C18 0.90558 (13) 0.8060 (2) 1.1716 (2) 0.0297 (5)
H18 0.9016 0.8961 1.1874 0.036*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
S1 0.0282 (3) 0.0197 (3) 0.0246 (3) 0.00178 (18) 0.00181 (19) 0.00051 (18)
S2A 0.0229 (3) 0.0257 (3) 0.0265 (3) −0.0011 (2) 0.0022 (2) −0.0008 (2)
C16A 0.0229 (3) 0.0257 (3) 0.0265 (3) −0.0011 (2) 0.0022 (2) −0.0008 (2)
S2B 0.0229 (3) 0.0257 (3) 0.0265 (3) −0.0011 (2) 0.0022 (2) −0.0008 (2)
C16B 0.0229 (3) 0.0257 (3) 0.0265 (3) −0.0011 (2) 0.0022 (2) −0.0008 (2)
O1 0.0189 (6) 0.0199 (6) 0.0177 (6) 0.0015 (5) 0.0001 (5) 0.0003 (5)
O2 0.0213 (7) 0.0510 (10) 0.0218 (7) −0.0010 (6) 0.0057 (6) −0.0044 (6)
N3 0.0175 (7) 0.0216 (8) 0.0184 (8) 0.0028 (6) 0.0006 (6) −0.0007 (6)
N1 0.0161 (8) 0.0234 (8) 0.0201 (8) 0.0005 (6) 0.0037 (6) 0.0027 (6)
N4 0.0196 (8) 0.0219 (8) 0.0197 (8) 0.0030 (6) 0.0022 (6) 0.0002 (6)
N2 0.0170 (8) 0.0260 (8) 0.0201 (8) 0.0035 (6) 0.0011 (6) 0.0002 (7)
C1 0.0175 (9) 0.0190 (9) 0.0244 (10) −0.0012 (7) 0.0030 (7) 0.0003 (7)
C15 0.0141 (8) 0.0219 (9) 0.0191 (9) 0.0009 (7) 0.0019 (7) 0.0014 (7)
C14 0.0128 (8) 0.0209 (9) 0.0204 (9) 0.0022 (7) 0.0029 (7) 0.0023 (7)
C13 0.0143 (8) 0.0241 (10) 0.0182 (9) 0.0006 (7) 0.0031 (7) −0.0016 (7)
C6 0.0216 (10) 0.0233 (10) 0.0239 (10) −0.0022 (8) 0.0034 (8) 0.0000 (8)
C9 0.0218 (10) 0.0248 (10) 0.0245 (10) 0.0031 (8) 0.0021 (8) 0.0047 (8)
C11 0.0177 (9) 0.0309 (11) 0.0211 (9) 0.0008 (8) 0.0031 (7) 0.0060 (8)
C4 0.0163 (9) 0.0309 (11) 0.0360 (11) −0.0025 (8) 0.0000 (8) 0.0014 (9)
C3 0.0228 (10) 0.0351 (12) 0.0267 (10) −0.0024 (8) −0.0019 (8) 0.0032 (9)
C2 0.0197 (9) 0.0309 (11) 0.0246 (10) −0.0008 (8) 0.0042 (8) 0.0010 (8)
C10 0.0177 (9) 0.0284 (10) 0.0224 (9) −0.0002 (8) 0.0024 (7) 0.0055 (8)
C8 0.0203 (9) 0.0228 (10) 0.0290 (10) −0.0003 (7) 0.0030 (8) 0.0035 (8)
C5 0.0197 (10) 0.0331 (11) 0.0307 (11) −0.0032 (8) 0.0087 (8) −0.0001 (9)
C12 0.0204 (9) 0.0295 (10) 0.0174 (9) 0.0047 (8) 0.0017 (7) −0.0042 (8)
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C17 0.0173 (9) 0.0420 (12) 0.0211 (9) −0.0069 (8) 0.0027 (7) −0.0057 (9)
C7 0.0326 (11) 0.0442 (13) 0.0272 (11) −0.0067 (10) 0.0117 (9) −0.0083 (10)
C18 0.0240 (10) 0.0230 (10) 0.0432 (12) −0.0017 (8) 0.0102 (9) −0.0017 (9)
Geometric parameters (Å, º) 
S1—C13 1.647 (2) C9—H9A 0.97
S2A—C18 1.655 (2) C9—H9B 0.97
S2A—C15 1.6988 (19) C11—C10 1.522 (3)
C16A—C17 1.489 (3) C11—H11A 0.97
C16A—C15 1.542 (2) C11—H11B 0.97
C16A—H16A 0.93 C4—C3 1.381 (3)
O1—C14 1.369 (2) C4—C5 1.386 (3)
O1—C13 1.381 (2) C4—H4 0.93
O2—C6 1.367 (3) C3—C2 1.396 (3)
O2—C7 1.434 (3) C3—H3 0.93
N3—C13 1.337 (2) C2—H2 0.93
N3—N4 1.393 (2) C10—H10A 0.97
N3—C12 1.487 (2) C10—H10B 0.97
N1—C1 1.425 (2) C8—H8A 0.97
N1—C11 1.460 (2) C8—H8B 0.97
N1—C8 1.469 (2) C5—H5 0.93
N4—C14 1.290 (2) C12—H12A 0.97
N2—C12 1.427 (2) C12—H12B 0.97
N2—C9 1.460 (2) C17—C18 1.349 (3)
N2—C10 1.464 (3) C17—H17 0.93
C1—C2 1.386 (3) C7—H7A 0.96
C1—C6 1.412 (3) C7—H7B 0.96
C15—C14 1.441 (3) C7—H7C 0.96
C6—C5 1.388 (3) C18—H18 0.93
C9—C8 1.522 (3)
C18—S2A—C15 92.58 (10) C3—C4—C5 120.10 (19)
C17—C16A—C15 101.32 (13) C3—C4—H4 120
C17—C16A—H16A 129.3 C5—C4—H4 120
C15—C16A—H16A 129.3 C4—C3—C2 119.49 (19)
C14—O1—C13 105.85 (14) C4—C3—H3 120.3
C6—O2—C7 116.52 (17) C2—C3—H3 120.3
C13—N3—N4 112.23 (15) C1—C2—C3 121.48 (19)
C13—N3—C12 126.27 (17) C1—C2—H2 119.3
N4—N3—C12 121.49 (15) C3—C2—H2 119.3
C1—N1—C11 115.34 (15) N2—C10—C11 108.46 (16)
C1—N1—C8 112.16 (15) N2—C10—H10A 110
C11—N1—C8 110.80 (15) C11—C10—H10A 110
C14—N4—N3 103.26 (15) N2—C10—H10B 110
C12—N2—C9 114.55 (15) C11—C10—H10B 110
C12—N2—C10 116.12 (16) H10A—C10—H10B 108.4
C9—N2—C10 111.25 (15) N1—C8—C9 110.57 (16)
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C2—C1—C6 118.29 (18) N1—C8—H8A 109.5
C2—C1—N1 123.40 (17) C9—C8—H8A 109.5
C6—C1—N1 118.28 (17) N1—C8—H8B 109.5
C14—C15—C16A 123.32 (15) C9—C8—H8B 109.5
C14—C15—S2A 122.32 (14) H8A—C8—H8B 108.1
C16A—C15—S2A 114.33 (12) C4—C5—C6 120.56 (19)
N4—C14—O1 113.53 (16) C4—C5—H5 119.7
N4—C14—C15 129.37 (18) C6—C5—H5 119.7
O1—C14—C15 117.09 (16) N2—C12—N3 115.51 (15)
N3—C13—O1 105.12 (16) N2—C12—H12A 108.4
N3—C13—S1 132.09 (15) N3—C12—H12A 108.4
O1—C13—S1 122.77 (14) N2—C12—H12B 108.4
O2—C6—C5 123.60 (18) N3—C12—H12B 108.4
O2—C6—C1 116.35 (17) H12A—C12—H12B 107.5
C5—C6—C1 120.05 (19) C18—C17—C16A 117.01 (18)
N2—C9—C8 109.84 (16) C18—C17—H17 121.5
N2—C9—H9A 109.7 C16A—C17—H17 121.5
C8—C9—H9A 109.7 O2—C7—H7A 109.5
N2—C9—H9B 109.7 O2—C7—H7B 109.5
C8—C9—H9B 109.7 H7A—C7—H7B 109.5
H9A—C9—H9B 108.2 O2—C7—H7C 109.5
N1—C11—C10 109.26 (15) H7A—C7—H7C 109.5
N1—C11—H11A 109.8 H7B—C7—H7C 109.5
C10—C11—H11A 109.8 C17—C18—S2A 114.76 (17)
N1—C11—H11B 109.8 C17—C18—H18 122.6
C10—C11—H11B 109.8 S2A—C18—H18 122.6
H11A—C11—H11B 108.3
C13—N3—N4—C14 −0.5 (2) N1—C1—C6—O2 0.7 (3)
C12—N3—N4—C14 178.38 (15) C2—C1—C6—C5 1.5 (3)
C11—N1—C1—C2 22.5 (3) N1—C1—C6—C5 179.97 (18)
C8—N1—C1—C2 −105.7 (2) C12—N2—C9—C8 −167.82 (16)
C11—N1—C1—C6 −155.90 (18) C10—N2—C9—C8 58.0 (2)
C8—N1—C1—C6 76.0 (2) C1—N1—C11—C10 171.49 (16)
C17—C16A—C15—C14 −177.76 (16) C8—N1—C11—C10 −59.7 (2)
C17—C16A—C15—S2A 0.16 (15) C5—C4—C3—C2 1.1 (3)
C18—S2A—C15—C14 177.79 (16) C6—C1—C2—C3 −0.5 (3)
C18—S2A—C15—C16A −0.16 (13) N1—C1—C2—C3 −178.91 (19)
N3—N4—C14—O1 0.53 (19) C4—C3—C2—C1 −0.8 (3)
N3—N4—C14—C15 −178.64 (17) C12—N2—C10—C11 165.92 (15)
C13—O1—C14—N4 −0.4 (2) C9—N2—C10—C11 −60.7 (2)
C13—O1—C14—C15 178.90 (15) N1—C11—C10—N2 60.7 (2)
C16A—C15—C14—N4 −178.37 (16) C1—N1—C8—C9 −172.53 (16)
S2A—C15—C14—N4 3.9 (3) C11—N1—C8—C9 57.0 (2)
C16A—C15—C14—O1 2.5 (2) N2—C9—C8—N1 −55.2 (2)
S2A—C15—C14—O1 −175.28 (13) C3—C4—C5—C6 −0.2 (3)
N4—N3—C13—O1 0.29 (19) O2—C6—C5—C4 178.1 (2)
C12—N3—C13—O1 −178.53 (15) C1—C6—C5—C4 −1.2 (3)
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N4—N3—C13—S1 −178.25 (15) C9—N2—C12—N3 −52.8 (2)
C12—N3—C13—S1 2.9 (3) C10—N2—C12—N3 79.1 (2)
C14—O1—C13—N3 0.03 (18) C13—N3—C12—N2 110.8 (2)
C14—O1—C13—S1 178.74 (13) N4—N3—C12—N2 −67.9 (2)
C7—O2—C6—C5 −24.0 (3) C15—C16A—C17—C18 −0.1 (2)
C7—O2—C6—C1 155.31 (19) C16A—C17—C18—S2A 0.0 (2)
C2—C1—C6—O2 −177.78 (18) C15—S2A—C18—C17 0.11 (17)
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the S2A/C15/C16A/C17/C18 ring.
D—H···A D—H H···A D···A D—H···A
C12—H12A···S1i 0.97 2.95 3.860 (2) 157
C17—H17···O1ii 0.93 2.69 3.475 (2) 143
C5—H5···Cg1iii 0.93 2.95 3.660 (2) 135
Symmetry codes: (i) x, −y+1/2, z−1/2; (ii) −x+2, y+1/2, −z+5/2; (iii) −x+1, −y+1, −z+2.
